Neuropsychological change in schizophrenia after 6 months of double-blind treatment with quetiapine or haloperidol

被引：2
|
作者：
Purdon, SE [1 ]
Malla, A [1 ]
Labelle, A [1 ]
Litt, W [1 ]
机构：
[1] Alberta Hosp, Edmonton, AB T5J 2J7, Canada
来源：
SCHIZOPHRENIA RESEARCH | 2000年 / 41卷 / 01期
关键词：
D O I：
10.1016/S0920-9964(00)90808-9
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
B82
引用
收藏
页码：205 / 206
页数：2
相关论文
共 50 条
  • [11] A double-blind, randomised, controlled trial of quetiapine versus haloperidol for the treatment of delirium: a preliminary report
    Maneeton, B.
    Maneeton, N.
    Srisurapanont, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S557 - S557
  • [12] A double-blind, randomized comparative trial of amisulpride versus olanzapine for 6 months in the treatment of schizophrenia
    Mortimer, A
    Martin, S
    Lôo, H
    Peuskens, J
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2004, 19 (02) : 63 - 69
  • [13] Neuropsychological change in early phase schizophrenia over twelve months of treatment with olanzapine, risperidone, or haloperidol
    Purdon, S
    Jones, B
    Chouinard, G
    Stip, E
    Tollefson, G
    SCHIZOPHRENIA RESEARCH, 1998, 29 (1-2) : 152 - 153
  • [14] Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol
    Purdon, SE
    Jones, BDW
    Stip, E
    Labelle, A
    Addington, D
    David, SR
    Breier, A
    Tollefson, GD
    ARCHIVES OF GENERAL PSYCHIATRY, 2000, 57 (03) : 249 - 258
  • [15] Treatment of methamphetamine-induced psychosis: a double-blind randomized controlled trial comparing haloperidol and quetiapine
    Verachai, Viroj
    Rukngan, Warangkana
    Chawanakrasaesin, Kachornwan
    Nilaban, Sumnao
    Suwanmajo, Somporn
    Thanateerabunjong, Rossukon
    Kaewkungwal, Jaranit
    Kalayasiri, Rasmon
    PSYCHOPHARMACOLOGY, 2014, 231 (16) : 3099 - 3108
  • [16] Treatment of methamphetamine-induced psychosis: a double-blind randomized controlled trial comparing haloperidol and quetiapine
    Viroj Verachai
    Warangkana Rukngan
    Kachornwan Chawanakrasaesin
    Sumnao Nilaban
    Somporn Suwanmajo
    Rossukon Thanateerabunjong
    Jaranit Kaewkungwal
    Rasmon Kalayasiri
    Psychopharmacology, 2014, 231 : 3099 - 3108
  • [17] SULPIRIDE VERSUS HALOPERIDOL IN SCHIZOPHRENIA - DOUBLE-BLIND COMPARATIVE TRIAL
    CASSANO, GB
    CASTROGIOVANNI, P
    CONTI, L
    BONOLLO, L
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1975, 17 (02): : 189 - 201
  • [18] A DOUBLE-BLIND COMPARATIVE MULTICENTER STUDY OF REMOXIPRIDE AND HALOPERIDOL IN SCHIZOPHRENIA
    ANDERSEN, J
    KORNER, A
    OSTERGAARD, P
    FENSBO, C
    BIRKETSMITH, M
    THIESEN, S
    HANSEN, NR
    FOGH, M
    KRISTENSEN, M
    MOLLERNIELSEN, EM
    JENSEN, B
    BJORUM, N
    ACTA PSYCHIATRICA SCANDINAVICA, 1990, 82 : 104 - 107
  • [19] CLONAZEPAM HALOPERIDOL COMBINATION THERAPY IN SCHIZOPHRENIA - A DOUBLE-BLIND STUDY
    ALTAMURA, AC
    MAURI, MC
    MANTERO, M
    BRUNETTI, M
    ACTA PSYCHIATRICA SCANDINAVICA, 1987, 76 (06) : 702 - 706
  • [20] A DOUBLE-BLIND COMPARATIVE MULTICENTER STUDY OF REMOXIPRIDE AND HALOPERIDOL IN SCHIZOPHRENIA
    LINDSTROM, LH
    WIESELGREN, IM
    STRUWE, G
    KRISTJANSSON, E
    AKSELSON, S
    ARTHUR, H
    ANDERSEN, T
    LINDGREN, S
    NORMAN, O
    NAIMELL, L
    STENING, G
    ACTA PSYCHIATRICA SCANDINAVICA, 1990, 82 : 130 - 135
12345